3.302 articles found

Neuroimaging and serum biomarkers of neurodegeneration and neuroplasticity in Parkinson's disease patients treated by intermittent theta-burst stimulation over the bilateral primary motor area: a randomized, double-blind, sham-controlled, crossover trial study.

Rashid-López R, Macías-García P, Sánchez-Fernández FL, Cano-Cano F, Sarrias-Arrabal E, Sanmartino F, Méndez-Bértolo C, Lozano-Soto E, Gutiérrez-Cortés R, González-Moraleda Á, Forero L, López-Sosa F, Zuazo A, Gómez-Molinero R, Gómez-Ramírez J, Paz-Expósito J, Rubio-Esteban G, Espinosa-Rosso R, Cruz-Gómez ÁJ, González-Rosa JJ.

Front Aging Neurosci · 2023-10-05

DOI: 10.3389/fnagi.2023.1258315PMID: 37869372

EEG-based biomarkers for optimizing deep brain stimulation contact configuration in Parkinson's disease.

Peeters J, Van Bogaert T, Boogers A, Dembek TA, Gransier R, Wouters J, Vandenberghe W, De Vloo P, Nuttin B, Mc Laughlin M.

Front Neurosci · 2023-10-05

DOI: 10.3389/fnins.2023.1275728PMID: 37869517

Inflammatory Blood Biomarkers Are Associated with Long-Term Clinical Disease Severity in Parkinson's Disease.

Hepp DH, van Wageningen TA, Kuiper KL, van Dijk KD, Oosterveld LP, Berendse HW, van de Berg WDJ.

Int J Mol Sci · 2023-10-05

DOI: 10.3390/ijms241914915PMID: 37834363

Early detection of Parkinson's disease: Systematic analysis of the influence of the eyes on quantitative biomarkers in resting state electroencephalography.

Gimenez-Aparisi G, Guijarro-Estelles E, Chornet-Lurbe A, Ballesta-Martinez S, Pardo-Hernandez M, Ye-Lin Y.

Heliyon · 2023-10-04

DOI: 10.1016/j.heliyon.2023.e20625PMID: 37829809

Early detection of Parkinson's disease: Systematic analysis of the influence of the eyes on quantitative biomarkers in resting state electroencephalography

Gimenez-Aparisi G, Guijarro-Estelles E, Chornet-Lurbe A, Ballesta-Martinez S, Pardo-Hernandez M, Ye-Lin Y.

Heliyon · 2023-10-01

Brain MRI Biomarkers in Isolated Rapid Eye Movement Sleep Behavior Disorder: Where Are We? A Systematic Review.

Grimaldi S, Guye M, Bianciardi M, Eusebio A.

Brain Sci · 2023-09-30

DOI: 10.3390/brainsci13101398PMID: 37891767

Diagnosing multiple system atrophy: current clinical guidance and emerging molecular biomarkers.

Goolla M, Cheshire WP, Ross OA, Kondru N.

Front Neurol · 2023-09-29

DOI: 10.3389/fneur.2023.1210220PMID: 37840912

Wearables for Parkinson's: Fast-Paced toward Novel Outcome Measures.

Janssen Daalen JM, Oosterhof TH, Bloem BR, Darweesh SKL.

Mov Disord · 2023-09-29

DOI: 10.1002/mds.29608PMID: 37776035

Toward Personalized Medicine Approaches for Parkinson Disease Using Digital Technologies.

Khanna A, Jones G.

JMIR Form Res · 2023-09-27

DOI: 10.2196/47486PMID: 37756050

Enhanced sensitivity to disease progression using digital health technologies in early Parkinson’s disease

Czech M, Badley D, Yang L, Shen J, Crouthamel M, Kangarloo T, Dorsey R, Adams J, Cosman J.

· 2023-09-26

DOI: 10.21203/rs.3.rs-3235574/v1

Prospective role of PAK6 and 14-3-3γ as biomarkers for Parkinson’s disease

Civiero L, Giusto E, Maistrello L, Iannotta L, Giusti V, Iovino L, Bandopadhyay R, Antonini A, Bubacco L, Barresi R, Plotegher N, Greggio E.

· 2023-09-25

DOI: 10.21203/rs.3.rs-3334243/v1

Tau: a biomarker of Huntington's disease.

Lepinay E, Cicchetti F.

Mol Psychiatry · 2023-09-25

DOI: 10.1038/s41380-023-02230-9PMID: 37749233